Related Experiment Videos
Trk receptor alterations in Alzheimer's disease
1Department of Pharmacology, School of Medicine, University of Auckland, New Zealand.
Brain Research. Molecular Brain Research
|November 1, 1996
Summary
TrkA and TrkB receptors, crucial for nerve cell function, are elevated in Alzheimer's disease brains, particularly near beta-amyloid plaques. This suggests a potential role for these neurotrophin receptors in Alzheimer's disease development.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Neurotrophin receptors, such as TrkA and TrkB, play vital roles in neuronal survival, growth, and function.
- Dysregulation of these receptors has been implicated in various neurodegenerative disorders.
Purpose of the Study:
- To investigate the expression patterns of TrkA and TrkB receptors in human brain tissue from normal, Huntington's disease, and Alzheimer's disease individuals.
- To explore the potential association between Trk receptor expression and neuropathological hallmarks of Alzheimer's disease, such as beta-amyloid plaques.
Main Methods:
- Immunohistochemistry was employed to visualize Trk receptor protein expression in brain tissue.
- In-situ hybridization was used to determine the mRNA levels of Trk receptors.
- Western blotting was utilized for quantitative analysis of receptor expression.
Main Results:
- Alzheimer's disease hippocampi showed increased TrkA receptor levels in astrocytes, co-localizing with some beta-amyloid plaques.
- Elevated levels of truncated TrkB receptors were detected in senile plaques, while full-length TrkB was found in glial-like cells.
- In-situ hybridization confirmed elevated Trk receptor mRNA levels in Alzheimer's disease brains.
Conclusions:
- The aberrant expression of TrkA and TrkB receptors in astrocytes and plaques in Alzheimer's disease brains may be linked to beta-amyloid deposition.
- These findings suggest a potential involvement of Trk receptors in the pathogenesis and progression of Alzheimer's disease.